Previous close | 85.76 |
Open | 85.30 |
Bid | 85.05 x 800 |
Ask | 85.09 x 1000 |
Day's range | 84.78 - 85.90 |
52-week range | 62.11 - 97.49 |
Volume | |
Avg. volume | 2,214,217 |
Market cap | 21.738B |
Beta (5Y monthly) | 1.24 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 1.60 (1.87%) |
Ex-dividend date | 21 Mar 2024 |
1y target est | N/A |
IFF's Pharma Solutions division will highlight innovative solutions to help pharmaceutical manufacturers seeking science-backed excipients with effective strategies to support their nitrosamine risk mitigation plans at Excipient World 2024, May 13-15, Gaylord Palms Resort and Convention Center, Kissimmee, Florida at booth 214.
NEW YORK, April 16, 2024--IFF (NYSE:IFF) today announced that it will release its first quarter 2024 earnings results following the market close on Monday, May 6, 2024. The management team will host a live webcast on Tuesday, May 7, 2024 at 9:00 a.m. ET to discuss results and outlook with the investor community.
NEW YORK, April 03, 2024--IFF (NYSE: IFF) today announced that it has completed the previously announced divestiture of its Cosmetic Ingredients business to Clariant, a sustainably focused specialty chemicals company. As a part of Clariant, the business will continue to deliver innovative ingredients for the cosmetic and personal care product portfolio.